Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma is a research paper published in Science Advances (2023). On theSindex it has a DataRank of 0. It has been cited 65 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA016520
NIH HHS
Grant: S10 OD023465
NCI NIH HHS
Grant: P01 CA214278
National Institutes of Health
Grant: 2P30CA016520-35
Abramson Cancer Center Support Grant
National Institutes of Health
Grant: 3P01CA214278-02S1
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
National Institutes of Health
Grant: 1S10OD023465-01A1
Aperio VERSA Digital Slide Scanner, eSlide Manager Database, and Advanced Image Analysis Software
National Institutes of Health
Grant: 1S10RR013039-01
MICROPLATE SCINTILLATION/LUMINESCENCE/FLOUR COUNTER
Fields of Study
Keywords